Tumor PD-1 ligand (PD-L1) expression reflects an immune-active microenvironment; although it is associated with other immunosuppressive molecules including PD-1 and PD-L2, PD-L1 expression is the single factor most closely correlated with response to anti-PD-1 blockade4. This evidence concerns the gene PDCD1 and neoplasm.